CHARLES SCHWAB INVESTMENT MANAGEMENT INC - TALIS BIOMEDICAL CORP ownership

Back to all holdings Add to watchlist

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 36 filers reported holding TALIS BIOMEDICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Filings

EDGAR links

External links

Quarter-by-quarter ownership

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of TALIS BIOMEDICAL CORP
	Value		Shares		Weighting
Q1 2022	$45,000	-69.6%	31,324	-14.7%	0.00%	–
Q4 2021	$148,000	-35.7%	36,714	0.0%	0.00%	–
Q3 2021	$230,000	-78.3%	36,714	-61.8%	0.00%	–
Q2 2021	$1,059,000	-12.0%	95,996	+2.5%	0.00%	–
Q1 2021	$1,204,000	–	93,659	–	0.00%	–
Download

Other shareholders

TALIS BIOMEDICAL CORP shareholders Q2 2022
Name	Shares	Value	Weighting ↓
Greenlight Capital	2,235,783	$1,073,176	0.05%
WELLS FARGO & COMPANY/MN	174	$84	0.00%
NORTHERN TRUST CORP	27,860	$13,373	0.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0	$0	0.00%
GEODE CAPITAL MANAGEMENT, LLC	140,530	$67,454	0.00%
STATE STREET CORP	47,436	$22,769	0.00%
MILLENNIUM MANAGEMENT LLC	91,463	$43,902	0.00%
DEUTSCHE BANK AG\	45,294	$21,741	0.00%
MORGAN STANLEY	61,857	$29,691	0.00%
BlackRock Inc.	76,307	$36,628	0.00%

View complete list of TALIS BIOMEDICAL CORP shareholders